» Articles » PMID: 19321255

Knockdown of SMYD3 by RNA Interference Down-regulates C-Met Expression and Inhibits Cells Migration and Invasion Induced by HGF

Overview
Journal Cancer Lett
Specialty Oncology
Date 2009 Mar 27
PMID 19321255
Citations 33
Authors
Affiliations
Soon will be listed here.
Abstract

We previously reported that over-expression of SMYD3, a histone H3-K4 specific di- and tri-methyltransferase, plays a key role in cell viability, adhesion, migration and invasion. In this study, we investigated the mechanisms underlying these phenomena and found that knocking down SMYD3 expression in tumor cells significantly reduced the biological function of HGF and inhibited carcinoma cells migration and invasion. Due to the fact that the proto-oncogene c-Met encodes the high-affinity receptor for HGF, and the HGF-c-Met signaling plays a critical role in the tumor genesis, we further identified the partial correlation between SMYD3 and c-Met. The results showed that high expression of c-Met accompanied with over-expression of SMYD3. Silencing SMYD3 expression in tumor cells by specific shRNAs down-regulated c-Met gene transcription, while over-expressing SMYD3 induced c-Met transcription. Moreover, we demonstrated here that two SMYD3 binding sites within the c-Met core promoter region were significant in the transactivation of c-Met. The present findings provide significant insights into the epigenetic regulatory mechanisms of oncogene c-Met expression, and develop the strategies that may inhibit the progression of cancer migration and invasion.

Citing Articles

Epigenetic modification of hepatitis B virus infection and related hepatocellular carcinoma.

Zhang Y, Cao W, Wang S, Zhang L, Li X, Zhang Z Virulence. 2024; 15(1):2421231.

PMID: 39460469 PMC: 11583590. DOI: 10.1080/21505594.2024.2421231.


SMYD3 associates with the NuRD (MTA1/2) complex to regulate transcription and promote proliferation and invasiveness in hepatocellular carcinoma cells.

Yang Y, Qiu R, Zhao S, Shen L, Tang B, Weng Q BMC Biol. 2022; 20(1):294.

PMID: 36575438 PMC: 9795622. DOI: 10.1186/s12915-022-01499-6.


Mast cell marker gene signature in head and neck squamous cell carcinoma.

Cai Z, Tang B, Chen L, Lei W BMC Cancer. 2022; 22(1):577.

PMID: 35610596 PMC: 9128261. DOI: 10.1186/s12885-022-09673-3.


Identifying novel SMYD3 interactors on the trail of cancer hallmarks.

Fasano C, Lepore Signorile M, De Marco K, Forte G, Sanese P, Grossi V Comput Struct Biotechnol J. 2022; 20:1860-1875.

PMID: 35495117 PMC: 9039736. DOI: 10.1016/j.csbj.2022.03.037.


Playing on the Dark Side: SMYD3 Acts as a Cancer Genome Keeper in Gastrointestinal Malignancies.

Sanese P, Fasano C, Simone C Cancers (Basel). 2021; 13(17).

PMID: 34503239 PMC: 8430692. DOI: 10.3390/cancers13174427.